Memantine as an Example of a Fast, Voltage-Dependent, Open Channel N-Methyl-d-Aspartate Receptor Blocker

  • Chris G. Parsons
  • Kate Gilling
Part of the Methods in Molecular Biology™ book series (MIMB, volume 403)


Electrophysiological techniques can be used to great effect to help determine the mechanism of action of a compound. However, many factors can compromise the resulting data and their analysis, such as the speed of solution exchange, expression of additional ion channel populations including other ligand-gated receptors and voltage-gated channels, compounds having multiple binding sites, and current desensitization and rundown. In this chapter, such problems and their solutions are discussed and illustrated using data from experiments involving the uncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist memantine. Memantine differs from many other NMDA receptor channel blockers in that it is well tolerated and does not cause psychotomimetic effects at therapeutic doses. Various electrophysiological parameters of NMDA-induced current blockade by memantine have been proposed to be important in determining therapeutic tolerability, potency, onset and offset kinetics, and voltage dependency. These were all measured using whole cell patch-clamp techniques using hippocampal neurons. Full results are shown here for memantine, and these are summarized and compared with those from similar experiments with other NMDA channel blockers. The interpretation of these results is discussed, as are theories concerning the tolerability of NMDA channel blockers, with the aim of illustrating how electrophysiological data can be used to form and support a physiological hypothesis.

Key Words

NMDA uncompetitive concentration dependence concentration clamp voltage dependence kinetics 


  1. 1.
    Reisberg, B., R. Doody, A. Stoffler, F. Schmitt, S. Ferris, and H.J. Motrius (2003) Memantine in moderate-to-sexere Alzheimer’s disease. M. Engl. J. Med. 348, 1333–1341.CrossRefGoogle Scholar
  2. 2.
    Tariot, P.N., M.R. Farlow, G.T. Grossberg, S.M. Graham, S. McDonald, and I. Gergel (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil – a randomized controlled trial. JAMA 291, 317–324.CrossRefPubMedGoogle Scholar
  3. 3.
    Parsons, C.G., W. Danysz, and G. Quack (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data. Neuropharmacology 38, 735–767.CrossRefPubMedGoogle Scholar
  4. 4.
    Danysz, W. and C.G. Parsons (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int. J. Geriatr. Psychiatry 18, S23–S32.CrossRefPubMedGoogle Scholar
  5. 5.
    Johnson, J.W. and S.E. Kotermanski (2006) Mechanism of action of memantine. Curr. Opin. Pharmacol. 6, 61–67.CrossRefPubMedGoogle Scholar
  6. 6.
    Parsons, C.G., R. Gruner, J. Rozental, J. Millar, and D. Lodge (1993) Patch-clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32, 1337–1350.CrossRefPubMedGoogle Scholar
  7. 7.
    Rogawski, M.A. (1993) Therapeutic potential of excitatory amino-acid antagonists – channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325–331.CrossRefPubMedGoogle Scholar
  8. 8.
    Blanpied, T.A., F.A. Boeckman, E. Aizenman, and J.W. Johnson (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J. Neurophysiol. 77, 309–323.PubMedGoogle Scholar
  9. 9.
    Bresink, I., T.A. Benke, V.J. Collett, A.J. Seal, C.G. Parsons, J.M. Henley, and G.L. Collingridge (1996) Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br. J. Pharmacol. 119, 195–204.PubMedGoogle Scholar
  10. 10.
    Chen, H.S.V. and S.A. Lipton (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. (Lond.) 499, 27–46.Google Scholar
  11. 11.
    Parsons, C.G., S. Hartmann, and P. Spielmanns (1998) Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones. Neuropharmacology 37, 719–727.CrossRefPubMedGoogle Scholar
  12. 12.
    Parsons, C.G., V.A. Panchenko, V.O. Pinchenko, A.Y. Tsyndrenko, and O.A. Krishtal (1996) Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur. J. Neurosci. 8, 446–454.CrossRefPubMedGoogle Scholar
  13. 13.
    Parsons, C.G., G. Quack, I. Bresink, L. Baran, E. Przegalinski, W. Kostowski, P. Krzascik, S. Hartmann, and W. Danysz (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in-vitro with anticonvulsive and motor impairment activity in-vivo. Neuropharmacology 34, 1239–1258.CrossRefPubMedGoogle Scholar
  14. 14.
    Sobolevsky, A. and S. Koshelev (1998) Two blocking sites of amino-adamantane derivatives in open N-methyl-d-aspartate channels. Biophys. J. 74, 1305–1319.CrossRefPubMedGoogle Scholar
  15. 15.
    Sobolevsky, A.I., S.G. Koshelev, and B.I. Khodorov (1998) Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons. J. Physiol. (Lond.) 512, 47–60.CrossRefGoogle Scholar
  16. 16.
    Clark, G.D., D.B. Clifford, and C.F. Zorumski (1990) The effect of agonist concentration, membrane voltage and calcium on N-methyl-D-aspartate receptor desensitization. Neuroscience 39, 787–797.CrossRefPubMedGoogle Scholar
  17. 17.
    Grantyn, R. and H.D. Lux (1988) Similarity and mutual exclusion of NMDA-activated and proton-activated transient Na+-currents in rat tectal neurons. Neurosci. Lett. 89, 198–203.CrossRefPubMedGoogle Scholar
  18. 18.
    Zilberter, Y., V. Uteshev, S. Sokolova, and B. Khodorov (1991) Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult-rat hippocampus. Mol. Pharmacol. 40, 337–341.PubMedGoogle Scholar
  19. 19.
    Johnson, J.W. and P. Ascher (1987) Glycine potentiates the NMDA response in cultured mouse-brain neurons. Nature 325, 529–531.CrossRefPubMedGoogle Scholar
  20. 20.
    Parsons, C.G., X.G. Zong, and H.D. Lux (1993) Whole-cell and single-channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br. J. Pharmacol. 109, 213–221.PubMedGoogle Scholar
  21. 21.
    Hashimoto, A. and T. Oka (1997) Free D-aspartate and D-serine in the mammalian brain and periphery. Prog. Neurobiol. 52, 325–353.CrossRefPubMedGoogle Scholar
  22. 22.
    Hamill, O.P., A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391, 85–100.CrossRefPubMedGoogle Scholar
  23. 23.
    Sigworth, F.J., H. Affolter, and E. Neher (1995) Design of the Epc-9, a computer-controlled patch-clamp amplifier. 2. Software. J. Neurosci. Methods 56, 203–215.CrossRefPubMedGoogle Scholar
  24. 24.
    Albuquerque, E.X., E.F.R. Pereira, N.G. Castro, M. Alkondon, S. Reinhardt, H. Schroder, and A. Maelicke (1995) Nicotinic receptor function in the mammalian central-nervous-system, in Diversity of Interacting Receptors. New York Acad Sciences: New York, pp. 48–72.Google Scholar
  25. 25.
    Black, M., T. Lanthorn, D. Small, G. Mealing, V. Lam, and P. Morley (1996) Study of potency, kinetics of block and toxicity of NMDA receptor antagonists using fura-2. Eur. J. Pharmacol. 317, 377–381.CrossRefPubMedGoogle Scholar
  26. 26.
    Rogawski, M.A., S.I. Yamaguchi, S.M. Jones, K.C. Rice, A. Thurkauf, and J.A. Monn (1991) Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D-aspartate antagonist (+/-)-5-aminocarbonyl-10,11-dihydro-5h-dibenzo[a,D]cyclohepten-5, 10-imine (Adci) – comparison with the structural analogs dizocilpine (Mk-801) and carbamazepine. J. Pharmacol. and Exp. Ther. 259, 30–37.Google Scholar
  27. 27.
    Frankiewicz, T., B. Potier, Z.I. Bashir, G.L. Collingridge, and C.G. Parsons (1996) Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br. J. Pharmacol. 117, 689–697.PubMedGoogle Scholar
  28. 28.
    Chen, H.S.V., J.W. Pellegrini, S.K. Aggarwal, S.Z. Lei, S. Warach, F.E. Jensen, and S.A. Lipton (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine – therapeutic advantage against NMDA receptor-mediated neurotoxicity. Journal of Neuroscience 12, 4427–4436.PubMedGoogle Scholar
  29. 29.
    Clements, J.D., R.A.J. Lester, G. Tong, C.E. Jahr, and G.L. Westbrook (1992) The time course of glutamate in the synaptic cleft. Science 258, 1498–1501.CrossRefPubMedGoogle Scholar
  30. 30.
    Nowak, L., P. Bregestovski, P. Ascher, A. Herbet, and A. Prochiantz (1984) Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307, 462–465.CrossRefPubMedGoogle Scholar
  31. 31.
    Andine, P., M. Sandberg, R. Bagenholm, A. Lehmann, and H. Hagberg (1991) Intracellular and extracellular changes of amino-acids in the cerebral-cortex of the neonatal rat during hypoxic-ischemia. Brain Res. Dev. Brain Res. 64, 115–120.CrossRefPubMedGoogle Scholar
  32. 32.
    Benveniste, H., J. Drejer, A. Schousboe, and N.H. Diemer (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral-ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369–1374.CrossRefPubMedGoogle Scholar
  33. 33.
    Buisson, A., J. Callebert, E. Mathieu, M. Plotkine, and R.G. Boulu (1992) Striatal protection induced by lesioning the substantia-nigra of rats subjected to focal ischemia. J. Neurochem. 59, 1153–1157.CrossRefPubMedGoogle Scholar
  34. 34.
    Globus, M.Y.T., R. Busto, E. Martinez, I. Valdes, W.D. Dietrich, and M.D. Ginsberg (1991) Comparative effect of transient global-ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric-acid in vulnerable and nonvulnerable brain-regions in the rat. J. Neurochem. 57, 470–478.CrossRefPubMedGoogle Scholar
  35. 35.
    Globus, M.Y.T., M.D. Ginsberg, and R. Busto (1991) Excitotoxic index – a biochemical marker of selective vulnerability. Neurosci. Lett. 127, 39–42.CrossRefPubMedGoogle Scholar
  36. 36.
    Mitani, A., Y. Andou, and K. Kataoka (1992) Selective vulnerability of hippocampal Ca1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil – brain microdialysis study. Neuroscience 48, 307–313.CrossRefPubMedGoogle Scholar
  37. 37.
    Sobkowicz, H.M. and S.M. Slapnick (1992) Neuronal sprouting and synapse formation in response to injury in the mouse organ of corti in culture. Int. J. Dev. Neurosci 10, 545–566.CrossRefPubMedGoogle Scholar
  38. 38.
    Sobkowicz, H.M., S.M. Slapnick, and B.K. August (1993) Presynaptic fibers of spiral neurons and reciprocal synapses in the organ of corti in culture. J. Neurocytol. 22, 979–993.CrossRefPubMedGoogle Scholar
  39. 39.
    Davies, S.N., D. Martin, J.D. Millar, J.A. Aram, J. Church, and D. Lodge (1988) Differences in results from invivo and invitro studies on the use-dependency of N-methylaspartate antagonism by Mk-801 and other phencyclidine receptor ligands. Eur. J. Pharmacol. 145, 141–151.CrossRefPubMedGoogle Scholar
  40. 40.
    Coan, E.J., A.J. Irving, and G.L. Collingridge (1989) Low-frequency activation of the NMDA receptor system can prevent the induction of Ltp. Neurosci. Lett. 105, 205–210.CrossRefPubMedGoogle Scholar
  41. 41.
    Frankiewicz, T. and C.G. Parsons (1999) Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices. Neuropharmacology 38, 1253–1259.CrossRefPubMedGoogle Scholar
  42. 42.
    Furukawa, Y., M. Okada, N. Akaike, T. Hayashi, and J. Nabekura (2000) Reduction of voltage-dependent magnesium block of N-methyl-D-aspartate receptor-mediated current by in vivo axonal injury. Neuroscience 96, 385–392.CrossRefPubMedGoogle Scholar
  43. 43.
    Rogawski, M.A. and G.L. Wenk (2003) The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease. CNS Drug Rev. 9, 275–308.CrossRefPubMedGoogle Scholar
  44. 44.
    Wang, L.Y. and J.F. Macdonald (1995) Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal-neurons. J. Physiol. (Lond.) 486, 83–95.Google Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Chris G. Parsons
  • Kate Gilling

There are no affiliations available

Personalised recommendations